OKYO Pharma Cash Flow Statement (2023-2025) | OKYO

Cash Flow Statement Sep2023 Mar2024 Sep2024 Mar2025 Sep2025
Operating Activities
Non-cash Items (Quarter) 0.56M1.96M
Depreciation, Depletion & Amortization
Amortization (Quarter) 0.30M0.15M1.84M0.01M0.42M
Change in Working Capital
Change in Accured Expenses (Quarter) 8.32M7.42M10.05M9.23M8.06M